{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:31Z","timestamp":1791925711458,"version":"4.3.4"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Minnesota College of Pharmacy","award":["Cloyd Neuropharmacology Fellowship"],"award-info":[{"award-number":["Cloyd Neuropharmacology Fellowship"]}]},{"name":"University of Minnesota College of Pharmacy","award":["SURRGE award program"],"award-info":[{"award-number":["SURRGE award program"]}]},{"name":"National Institutes of Health\/National Institute on Aging","award":["RF1AG058081, RF1AG077772, and R01AG081426"],"award-info":[{"award-number":["RF1AG058081, RF1AG077772, and R01AG081426"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12035-025-04859-9","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T02:22:09Z","timestamp":1742696529000},"page":"9507-9526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The HDL-Mimetic Peptide 4F Mitigates Vascular and Cortical Amyloid Pathology and Associated Neuroinflammation in a Transgenic Mouse Model of Cerebral Amyloid Angiopathy and Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8936-6652","authenticated-orcid":false,"given":"Rui","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Chernick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hottman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0616-6110","authenticated-orcid":false,"given":"Minwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8157-0587","authenticated-orcid":false,"given":"Manojkumar","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9245-7387","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"4859_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/alz.13320","volume":"20","author":"Alzheimer\u2019s Association","year":"2024","unstructured":"Alzheimer\u2019s Association (2024) 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 20:1\u2013146","journal-title":"Alzheimer\u2019s Dement"},{"key":"4859_CR2","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.3390\/ijms21103435","volume":"21","author":"L Gatti","year":"2020","unstructured":"Gatti L, Tinelli F, Scelzo E et al (2020) Understanding the pathophysiology of cerebral amyloid angiopathy. Int J Mol Sci 21:3435. https:\/\/doi.org\/10.3390\/ijms21103435","journal-title":"Int J Mol Sci"},{"key":"4859_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ANA.26516","volume":"93","author":"JL Hsu","year":"2023","unstructured":"Hsu JL, Wei YC, Toh CH et al (2023) Magnetic resonance images implicate that glymphatic alterations mediate cognitive dysfunction in Alzheimer disease. Ann Neurol 93:164\u2013174. https:\/\/doi.org\/10.1002\/ANA.26516","journal-title":"Ann Neurol"},{"key":"4859_CR4","doi-asserted-by":"publisher","first-page":"e00595","DOI":"10.1002\/BRB3.595","volume":"7","author":"MD Vald\u00e9s Hern\u00e1ndez","year":"2017","unstructured":"Vald\u00e9s Hern\u00e1ndez MD, Qiu X, Wang X et al (2017) Interhemispheric characterization of small vessel disease imaging markers after subcortical infarct. Brain Behav 7:e00595. https:\/\/doi.org\/10.1002\/BRB3.595","journal-title":"Brain Behav"},{"key":"4859_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/J.BRAINRESBULL.2020.04.008","volume":"161","author":"Y Xue","year":"2020","unstructured":"Xue Y, Liu N, Zhang M et al (2020) Concomitant enlargement of perivascular spaces and decrease in glymphatic transport in an animal model of cerebral small vessel disease. Brain Res Bull 161:78\u201383. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2020.04.008","journal-title":"Brain Res Bull"},{"key":"4859_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ANA.22112","volume":"69","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Wang Z et al (2011) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69:320\u2013327. https:\/\/doi.org\/10.1002\/ANA.22112","journal-title":"Ann Neurol"},{"key":"4859_CR7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/JNNP.49.11.1221","volume":"49","author":"MM Esiri","year":"1986","unstructured":"Esiri MM, Wilcock GK (1986) Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 49:1221. https:\/\/doi.org\/10.1136\/JNNP.49.11.1221","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4859_CR8","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/BRAIN\/AWT188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K et al (2013) Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain 136:2697\u20132706. https:\/\/doi.org\/10.1093\/BRAIN\/AWT188","journal-title":"Brain"},{"issue":"80","key":"4859_CR9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/SCIENCE.2111584","volume":"248","author":"E Levy","year":"1990","unstructured":"Levy E, Carman MD, Fernandez-Madrid IJ et al (1990) Mutation of the Alzheimer\u2019s disease amyloid gene in hereditary cerebral hemorrhage Dutch type. Science 248(80):1124\u20131126. https:\/\/doi.org\/10.1126\/SCIENCE.2111584","journal-title":"Science"},{"key":"4859_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/JNNP.58.6.699","volume":"58","author":"AR Wattendorff","year":"1995","unstructured":"Wattendorff AR, Frangione B, Luyendijk W, Bots GTAM (1995) Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J Neurol Neurosurg Psychiatry 58:699\u2013705. https:\/\/doi.org\/10.1136\/JNNP.58.6.699","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4859_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ANA.1009","volume":"49","author":"TJ Grabowski","year":"2001","unstructured":"Grabowski TJ, Cho HS, Vonsattel JPG et al (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49:697\u2013705. https:\/\/doi.org\/10.1002\/ANA.1009","journal-title":"Ann Neurol"},{"key":"4859_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/J.1365-2990.2010.01137.X","volume":"37","author":"J Attems","year":"2011","unstructured":"Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Review: Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37:75\u201393. https:\/\/doi.org\/10.1111\/J.1365-2990.2010.01137.X","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4859_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/D41573-024-00116-1","author":"A Mullard","year":"2024","unstructured":"Mullard A (2024) FDA approves third anti-amyloid antibody for Alzheimer disease. Nat Rev Drug Discov. https:\/\/doi.org\/10.1038\/D41573-024-00116-1","journal-title":"Nat Rev Drug Discov"},{"key":"4859_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M et al (2020) Cerebral amyloid angiopathy and Alzheimer disease \u2014 one peptide, two pathways. Nat Rev Neurol 16:30\u201342. https:\/\/doi.org\/10.1038\/s41582-019-0281-2","journal-title":"Nat Rev Neurol"},{"key":"4859_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE et al (2011) Amyloid-related imaging abnormalities (ARIA) in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimer\u2019s Dement 7:367\u2013385. https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2351","journal-title":"Alzheimer\u2019s Dement"},{"key":"4859_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/JAMANEUROL.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F et al (2022) Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol 79:13\u201321. https:\/\/doi.org\/10.1001\/JAMANEUROL.2021.4161","journal-title":"JAMA Neurol"},{"key":"4859_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13195-021-00813-8\/TABLES\/3","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson CJ, Zhang Y, Dhadda S et al (2021) A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimer\u2019s Res Ther 13:1\u201314. https:\/\/doi.org\/10.1186\/S13195-021-00813-8\/TABLES\/3","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"4859_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMOA2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Evans CD et al (2021) Donanemab in early Alzheimer\u2019s disease. New England J Med 384:1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMOA2100708","journal-title":"New England J Med"},{"key":"4859_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/JAMA.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD et al (2023) Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330:512\u2013527. https:\/\/doi.org\/10.1001\/JAMA.2023.13239","journal-title":"JAMA"},{"key":"4859_CR20","doi-asserted-by":"publisher","first-page":"e12112","DOI":"10.1002\/TRC2.12112","volume":"7","author":"SL Lowe","year":"2021","unstructured":"Lowe SL, Willis BA, Hawdon A et al (2021) Donanemab (LY3002813) dose-escalation study in Alzheimer\u2019s disease. Alzheimer\u2019s Dement Transl Res Clin Interv 7:e12112. https:\/\/doi.org\/10.1002\/TRC2.12112","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"4859_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10091276","volume":"10","author":"D Chernick","year":"2020","unstructured":"Chernick D, Zhong R, Li L (2020) The role of HDL and HDL mimetic peptides as potential therapeutics for Alzheimer \u2019 s disease. Biomolecules 10:1\u201328. https:\/\/doi.org\/10.3390\/biom10091276","journal-title":"Biomolecules"},{"key":"4859_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","volume":"21","author":"A Merched","year":"2000","unstructured":"Merched A, Xia Y, Visvikis S et al (2000) Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer\u2019s disease. Neurobiol Aging 21:27\u201330. https:\/\/doi.org\/10.1016\/S0197-4580(99)00103-7","journal-title":"Neurobiol Aging"},{"key":"4859_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3233\/JAD-140111","volume":"41","author":"YH Shih","year":"2014","unstructured":"Shih YH, Tsai KJ, Lee CW et al (2014) Apolipoprotein C-III is an amyloid-\u03b2-binding protein and an early marker for Alzheimer\u2019s disease. J Alzheimers Dis 41:855\u2013865. https:\/\/doi.org\/10.3233\/JAD-140111","journal-title":"J Alzheimers Dis"},{"key":"4859_CR24","doi-asserted-by":"publisher","first-page":"e209250","DOI":"10.1001\/jamanetworkopen.2020.9250","volume":"3","author":"M Koch","year":"2020","unstructured":"Koch M, DeKosky ST, Goodman M et al (2020) Association of apolipoprotein E in lipoprotein subspecies with risk of dementia. JAMA Netw open 3:e209250. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.9250","journal-title":"JAMA Netw open"},{"key":"4859_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fnagi.2019.00370","volume":"11","author":"Q Tang","year":"2020","unstructured":"Tang Q, Wang F, Yang J et al (2020) Revealing a novel landscape of the association between blood lipid levels and Alzheimer\u2019s disease: a meta-analysis of a case-control study. Front Aging Neurosci 11:370","journal-title":"Front Aging Neurosci"},{"key":"4859_CR26","doi-asserted-by":"publisher","first-page":"36945","DOI":"10.1074\/jbc.M110.127738","volume":"285","author":"I Lefterov","year":"2010","unstructured":"Lefterov I, Fitz NF, Cronican AA et al (2010) Apolipoprotein AI deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP\/PS1\u0394E9 mice. J Biol Chem 285:36945\u201336957. https:\/\/doi.org\/10.1074\/jbc.M110.127738","journal-title":"J Biol Chem"},{"key":"4859_CR27","doi-asserted-by":"publisher","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","volume":"285","author":"TL Lewis","year":"2010","unstructured":"Lewis TL, Cao D, Lu H et al (2010) Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of alzheimer disease. J Biol Chem 285:36958\u201336968. https:\/\/doi.org\/10.1074\/jbc.M110.127829","journal-title":"J Biol Chem"},{"key":"4859_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13195-019-0497-9","volume":"11","author":"EB Button","year":"2019","unstructured":"Button EB, Boyce GK, Wilkinson A et al (2019) ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP\/PS1 mice. Alzheimers Res Ther 11:44. https:\/\/doi.org\/10.1186\/s13195-019-0497-9","journal-title":"Alzheimers Res Ther"},{"key":"4859_CR29","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1021\/jm4005847","volume":"57","author":"LJ Leman","year":"2014","unstructured":"Leman LJ, Maryanoff BE, Ghadiri MR (2014) Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis. J Med Chem 57:2169\u20132196. https:\/\/doi.org\/10.1021\/jm4005847","journal-title":"J Med Chem"},{"key":"4859_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/cts.12487","volume":"10","author":"RL Dunbar","year":"2017","unstructured":"Dunbar RL, Movva R, Bloedon LAT et al (2017) Oral apolipoprotein A-I mimetic D-4F lowers HDL-inflammatory index in high-risk patients: a first-in-human multiple-dose, randomized controlled trial. Clin Transl Sci 10:455\u2013469. https:\/\/doi.org\/10.1111\/cts.12487","journal-title":"Clin Transl Sci"},{"key":"4859_CR31","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1194\/jlr.P800003-JLR200","volume":"49","author":"LAT Bloedon","year":"2008","unstructured":"Bloedon LAT, Dunbar R, Duffy D et al (2008) Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients. J Lipid Res 49:1344\u20131352. https:\/\/doi.org\/10.1194\/jlr.P800003-JLR200","journal-title":"J Lipid Res"},{"key":"4859_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/JPET.120.265876","volume":"375","author":"SK Swaminathan","year":"2020","unstructured":"Swaminathan SK, Zhou AL, Ahlschwede KM et al (2020) High-density lipoprotein mimetic peptide 4F efficiently crosses the blood-brain barrier and modulates amyloid-\u03b2 distribution between brain and plasma. J Pharmacol Exp Ther 375:308\u2013316. https:\/\/doi.org\/10.1124\/JPET.120.265876","journal-title":"J Pharmacol Exp Ther"},{"key":"4859_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/jnc.14554","volume":"147","author":"D Chernick","year":"2018","unstructured":"Chernick D, Ortiz-Valle S, Jeong A et al (2018) High-density lipoprotein mimetic peptide 4F mitigates amyloid-\u03b2-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia. J Neurochem 147:647\u2013662. https:\/\/doi.org\/10.1111\/jnc.14554","journal-title":"J Neurochem"},{"key":"4859_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","volume":"34","author":"SP Handattu","year":"2009","unstructured":"Handattu SP, Garber DW, Monroe CE et al (2009) Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis 34:525\u2013534. https:\/\/doi.org\/10.1016\/j.nbd.2009.03.007","journal-title":"Neurobiol Dis"},{"key":"4859_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.redox.2017.11.027","volume":"15","author":"D He","year":"2018","unstructured":"He D, Zhao M, Wu C et al (2018) Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1. Redox Biol 15:228\u2013242. https:\/\/doi.org\/10.1016\/j.redox.2017.11.027","journal-title":"Redox Biol"},{"key":"4859_CR36","doi-asserted-by":"publisher","first-page":"20296","DOI":"10.1074\/JBC.M312946200","volume":"279","author":"J Davis","year":"2004","unstructured":"Davis J, Xu F, Deane R et al (2004) Early-onset and robust cerebral microvascular accumulation of amyloid \u03b2-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid \u03b2-protein precursor. J Biol Chem 279:20296\u201320306. https:\/\/doi.org\/10.1074\/JBC.M312946200","journal-title":"J Biol Chem"},{"key":"4859_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0002-9440(10)62993-8","volume":"167","author":"J Miao","year":"2005","unstructured":"Miao J, Xu F, Davis J et al (2005) Cerebral microvascular amyloid \u03b2 protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid \u03b2 precursor protein. Am J Pathol 167:505\u2013515. https:\/\/doi.org\/10.1016\/S0002-9440(10)62993-8","journal-title":"Am J Pathol"},{"key":"4859_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1194\/jlr.M019844","volume":"53","author":"G Nayyar","year":"2012","unstructured":"Nayyar G, Mishra VK, Handattu SP et al (2012) Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides. J Lipid Res 53:849\u2013858. https:\/\/doi.org\/10.1194\/jlr.M019844","journal-title":"J Lipid Res"},{"key":"4859_CR39","doi-asserted-by":"publisher","first-page":"9552","DOI":"10.1523\/JNEUROSCI.2193-20.2020","volume":"40","author":"W Qu","year":"2020","unstructured":"Qu W, Li L (2020) Loss of TREM2 confers resilience to synaptic and cognitive impairment in aged mice. J Neurosci 40:9552\u20139563. https:\/\/doi.org\/10.1523\/JNEUROSCI.2193-20.2020","journal-title":"J Neurosci"},{"issue":"9","key":"4859_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40478-021-01231-5","volume":"91","author":"A Jeong","year":"2021","unstructured":"Jeong A, Cheng S, Zhong R et al (2021) Protein farnesylation is upregulated in Alzheimer\u2019s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer\u2019s model mice. Acta Neuropathol Commun 91(9):1\u201324. https:\/\/doi.org\/10.1186\/S40478-021-01231-5","journal-title":"Acta Neuropathol Commun"},{"key":"4859_CR41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/S12035-022-03082-0","volume":"60","author":"W Qu","year":"2023","unstructured":"Qu W, Jeong A, Zhong R et al (2023) Deletion of small GTPase H-Ras rescues memory deficits and reduces amyloid plaque-associated dendritic spine loss in transgenic Alzheimer\u2019s mice. Mol Neurobiol 60:495\u2013511. https:\/\/doi.org\/10.1007\/S12035-022-03082-0","journal-title":"Mol Neurobiol"},{"key":"4859_CR42","doi-asserted-by":"publisher","first-page":"35952","DOI":"10.1074\/jbc.M113.503904","volume":"288","author":"S Cheng","year":"2013","unstructured":"Cheng S, Cao D, Hottman DA et al (2013) Farnesyltransferase haplodeficiency reduces neuropathology and rescues cognitive function in a mouse model of Alzheimer disease. J Biol Chem 288:35952\u201335960. https:\/\/doi.org\/10.1074\/jbc.M113.503904","journal-title":"J Biol Chem"},{"key":"4859_CR43","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/nprot.2006.277","volume":"1","author":"DM Wilcock","year":"2006","unstructured":"Wilcock DM, Gordon MN, Morgan D (2006) Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat Protoc 1:1591\u20131595. https:\/\/doi.org\/10.1038\/nprot.2006.277","journal-title":"Nat Protoc"},{"key":"4859_CR44","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.humpath.2014.04.016","volume":"45","author":"CG Clement","year":"2019","unstructured":"Clement CG, Truong LD (2019) An evaluation of Congo red fluorescence for the diagnosis of amyloidosis. Hum Pathol 45:1766\u20131772. https:\/\/doi.org\/10.1016\/j.humpath.2014.04.016","journal-title":"Hum Pathol"},{"key":"4859_CR45","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1002\/ALZ.14222","volume":"20","author":"R Zhong","year":"2024","unstructured":"Zhong R, Xu Y, Williams JW, Li L (2024) Loss of TREM2 diminishes CAA despite an overall increase of amyloid load in Tg-SwDI mice. Alzheimer\u2019s Dement 20:7595\u20137612. https:\/\/doi.org\/10.1002\/ALZ.14222","journal-title":"Alzheimer\u2019s Dement"},{"issue":"37","key":"4859_CR46","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/S41587-019-0114-2","volume":"377","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL et al (2019) (2019) Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol 377(37):773\u2013782. https:\/\/doi.org\/10.1038\/S41587-019-0114-2","journal-title":"Nat Biotechnol"},{"key":"4859_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS et al (2020) Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med 26:131\u2013142. https:\/\/doi.org\/10.1038\/s41591-019-0695-9","journal-title":"Nat Med"},{"key":"4859_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-559\/FIGURES\/4","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:1\u201313. https:\/\/doi.org\/10.1186\/1471-2105-9-559\/FIGURES\/4","journal-title":"BMC Bioinformatics"},{"key":"4859_CR49","doi-asserted-by":"publisher","first-page":"1105690","DOI":"10.3389\/FNAGI.2023.1105690\/BIBTEX","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Tang W, Xiao W et al (2023) lncRNA-associated ceRNA network revealing the potential regulatory roles of ferroptosis and immune infiltration in Alzheimer\u2019s disease. Front Aging Neurosci 15:1105690. https:\/\/doi.org\/10.3389\/FNAGI.2023.1105690\/BIBTEX","journal-title":"Front Aging Neurosci"},{"key":"4859_CR50","doi-asserted-by":"publisher","first-page":"1404312","DOI":"10.3389\/FMICB.2024.1404312\/BIBTEX","volume":"15","author":"VD Krishna","year":"2024","unstructured":"Krishna VD, Chang A, Korthas H et al (2024) Impact of age and sex on neuroinflammation following SARS-CoV-2 infection in a murine model. Front Microbiol 15:1404312. https:\/\/doi.org\/10.3389\/FMICB.2024.1404312\/BIBTEX","journal-title":"Front Microbiol"},{"key":"4859_CR51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"4859_CR52","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D et al (1993) Apolipoprotein E: high-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977\u20131981. https:\/\/doi.org\/10.1073\/pnas.90.5.1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4859_CR53","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/PNAS.1220484110\/SUPPL_FILE\/PNAS.201220484SI.PDF","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K et al (2013) ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc Natl Acad Sci U S A 110:E1807\u2013E1816. https:\/\/doi.org\/10.1073\/PNAS.1220484110\/SUPPL_FILE\/PNAS.201220484SI.PDF","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4859_CR54","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.1074\/jbc.M112.411900","volume":"288","author":"S Ly","year":"2013","unstructured":"Ly S, Altman R, Petrlova J et al (2013) Binding of apolipoprotein E inhibits the oligomer growth of amyloid-\u03b2 peptide in solution as determined by fluorescence cross-correlation spectroscopy. J Biol Chem 288:11628\u201311635. https:\/\/doi.org\/10.1074\/jbc.M112.411900","journal-title":"J Biol Chem"},{"key":"4859_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M et al (2004) ApoE and clusterin cooperatively suppress A\u03b2 levels and deposition: evidence that ApoE regulates extracellular A\u03b2 metabolism in vivo. Neuron 41:193\u2013202. https:\/\/doi.org\/10.1016\/S0896-6273(03)00850-X","journal-title":"Neuron"},{"key":"4859_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/EXNR.1995.1080","volume":"136","author":"T Oda","year":"1995","unstructured":"Oda T, Wals P, Osterburg HH et al (1995) Clusterin (apoJ) alters the aggregation of amyloid \u03b2-peptide (A\u03b21-42) and forms slowly sedimenting a\u03b2 complexes that cause oxidative stress. Exp Neurol 136:22\u201331. https:\/\/doi.org\/10.1006\/EXNR.1995.1080","journal-title":"Exp Neurol"},{"key":"4859_CR57","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/SJ.JCBFM.9600419\/ASSET\/IMAGES\/LARGE\/10.1038_SJ.JCBFM.9600419-FIG4.JPEG","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD, Sagare AP, Friedman AE et al (2007) Transport pathways for clearance of human Alzheimer\u2019s amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27:909\u2013918. https:\/\/doi.org\/10.1038\/SJ.JCBFM.9600419\/ASSET\/IMAGES\/LARGE\/10.1038_SJ.JCBFM.9600419-FIG4.JPEG","journal-title":"J Cereb Blood Flow Metab"},{"key":"4859_CR58","doi-asserted-by":"publisher","first-page":"49789","DOI":"10.1074\/jbc.m308983200","volume":"278","author":"E-S Song","year":"2003","unstructured":"Song E-S, Juliano MA, Juliano L, Hersh LB (2003) Substrate activation of insulin-degrading enzyme (Insulysin). J Biol Chem 278:49789\u201349794. https:\/\/doi.org\/10.1074\/jbc.m308983200","journal-title":"J Biol Chem"},{"key":"4859_CR59","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El KJ et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"603","key":"4859_CR60","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41586-022-04521-7","volume":"6037903","author":"FJ Garcia","year":"2022","unstructured":"Garcia FJ, Sun N, Lee H et al (2022) (2022) Single-cell dissection of the human brain vasculature. Nat 6037903(603):893\u2013899. https:\/\/doi.org\/10.1038\/s41586-022-04521-7","journal-title":"Nat"},{"key":"4859_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-022-04596-2","volume":"13","author":"T Masuda","year":"2022","unstructured":"Masuda T, Amann L, Monaco G et al (2022) (2022) Specification of CNS macrophage subsets occurs postnatally in defined niches. Nat 13:1\u20139. https:\/\/doi.org\/10.1038\/s41586-022-04596-2","journal-title":"Nat"},{"key":"4859_CR62","doi-asserted-by":"publisher","first-page":"e1007755","DOI":"10.1371\/JOURNAL.PGEN.1007755","volume":"14","author":"V Nanda","year":"2018","unstructured":"Nanda V, Wang T, Pjanic M et al (2018) Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus. PLOS Genet 14:e1007755. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1007755","journal-title":"PLOS Genet"},{"issue":"554","key":"4859_CR63","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature25739","volume":"5547693","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck M, He L, M\u00e4e MA et al (2018) (2018) A molecular atlas of cell types and zonation in the brain vasculature. Nat 5547693(554):475\u2013480. https:\/\/doi.org\/10.1038\/nature25739","journal-title":"Nat"},{"issue":"7797","key":"4859_CR64","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41586-020-2026-1","volume":"579","author":"BW Chow","year":"2020","unstructured":"Chow BW, Nu\u00f1ez V, Kaplan L et al (2020) Caveolae in CNS arterioles mediate neurovascular coupling. Nature 579(7797):106. https:\/\/doi.org\/10.1038\/s41586-020-2026-1","journal-title":"Nature"},{"key":"4859_CR65","doi-asserted-by":"publisher","first-page":"593966","DOI":"10.3389\/FPHYS.2020.593966\/BIBTEX","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Qiao YN, Tao T et al (2020) Distinct roles of smooth muscle and non-muscle myosin light chain-mediated smooth muscle contraction. Front Physiol 11:593966. https:\/\/doi.org\/10.3389\/FPHYS.2020.593966\/BIBTEX","journal-title":"Front Physiol"},{"issue":"4","key":"4859_CR66","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","volume":"29","author":"TN Phoenix","year":"2016","unstructured":"Phoenix TN, Patmore DM, Boop S et al (2016) Medulloblastoma genotype dictates blood brain barrier phenotype. Cancer Cell 29(4):508. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.002","journal-title":"Cancer Cell"},{"issue":"7816","key":"4859_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2453-z","volume":"583","author":"AC Yang","year":"2020","unstructured":"Yang AC, Stevens MY, Chen MB et al (2020) Physiological blood\u2013brain transport is impaired with age by a shift in transcytosis. Nature. 583(7816):425\u2013430. https:\/\/doi.org\/10.1038\/s41586-020-2453-z","journal-title":"Nature."},{"key":"4859_CR68","doi-asserted-by":"publisher","first-page":"11097","DOI":"10.1073\/PNAS.1301257110\/SUPPL_FILE\/PNAS.201301257SI.PDF","volume":"110","author":"X Liu","year":"2013","unstructured":"Liu X, Zhang P, Bao Y et al (2013) Zinc finger protein ZBTB20 promotes toll-like receptor-triggered innate immune responses by repressing I\u03baB\u03b1 gene transcription. Proc Natl Acad Sci U S A 110:11097\u201311102. https:\/\/doi.org\/10.1073\/PNAS.1301257110\/SUPPL_FILE\/PNAS.201301257SI.PDF","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4859_CR69","doi-asserted-by":"publisher","first-page":"e0203760","DOI":"10.1371\/JOURNAL.PONE.0203760","volume":"13","author":"KA Jones","year":"2018","unstructured":"Jones KA, Luo Y, Dukes-Rimsky L et al (2018) Neurodevelopmental disorder-associated ZBTB20 gene variants affect dendritic and synaptic structure. PLoS ONE 13:e0203760. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0203760","journal-title":"PLoS ONE"},{"key":"4859_CR70","doi-asserted-by":"publisher","first-page":"E2739","DOI":"10.1073\/PNAS.1620507114\/SUPPL_FILE\/PNAS.1620507114.SAPP.PDF","volume":"114","author":"D Halim","year":"2017","unstructured":"Halim D, Wilson MP, Oliver D et al (2017) Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice. Proc Natl Acad Sci U S A 114:E2739\u2013E2747. https:\/\/doi.org\/10.1073\/PNAS.1620507114\/SUPPL_FILE\/PNAS.1620507114.SAPP.PDF","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4859_CR71","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1161\/ATVBAHA.116.308261","volume":"36","author":"MW Majesky","year":"2016","unstructured":"Majesky MW (2016) Vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 36:e82\u2013e86. https:\/\/doi.org\/10.1161\/ATVBAHA.116.308261","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4859_CR72","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169:1276-1290.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"key":"4859_CR73","doi-asserted-by":"publisher","first-page":"e6779","DOI":"10.1371\/JOURNAL.PONE.0006779","volume":"4","author":"M Uhrig","year":"2009","unstructured":"Uhrig M, Ittrich C, Wiedmann V et al (2009) New Alzheimer amyloid \u03b2 responsive genes identified in human neuroblastoma cells by hierarchical clustering. PLoS ONE 4:e6779. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0006779","journal-title":"PLoS ONE"},{"key":"4859_CR74","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/AJMG.A.33657","volume":"152A","author":"DM Milewicz","year":"2010","unstructured":"Milewicz DM, \u00d8stergaard JR, Ala-Kokko LM et al (2010) De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet Part A 152A:2437\u20132443. https:\/\/doi.org\/10.1002\/AJMG.A.33657","journal-title":"Am J Med Genet Part A"},{"key":"4859_CR75","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/138945008783755584","volume":"9","author":"M Navab","year":"2008","unstructured":"Navab M, Anantharamaiah G, Reddy S et al (2008) Apo A-1 mimetic peptides as atheroprotective agents in murine models. Curr Drug Targets 9:204\u2013209. https:\/\/doi.org\/10.2174\/138945008783755584","journal-title":"Curr Drug Targets"},{"key":"4859_CR76","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1194\/jlr.M011098","volume":"52","author":"CE Watson","year":"2011","unstructured":"Watson CE, Weissbach N, Kjems L et al (2011) Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function. J Lipid Res 52:361\u2013373. https:\/\/doi.org\/10.1194\/jlr.M011098","journal-title":"J Lipid Res"},{"issue":"10","key":"4859_CR77","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1194\/jlr.M600214-JLR200","volume":"47","author":"GM Buga","year":"2006","unstructured":"Buga GM, Frank JS, Mottino GA et al (2006) D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet. J Lipid Res 47(10):2148\u20132160. https:\/\/doi.org\/10.1194\/jlr.M600214-JLR200","journal-title":"J Lipid Res"},{"key":"4859_CR78","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.08.007","volume":"24","author":"JG Yan","year":"2015","unstructured":"Yan JG, Zhang LL, Agresti M et al (2015) Cumulative brain injury from motor vehicle-induced whole-body vibration and prevention by human apolipoprotein A-I molecule mimetic (4F) peptide (an Apo A-I Mimetic). J Stroke Cerebrovasc Dis 24:2759\u20132773. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.08.007","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4859_CR79","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/STROKEAHA.115.011046\/ASSET\/2E82DAF2-7D3C-40AB-A124-4D87A4113832\/ASSETS\/GRAPHIC\/214FIG04.JPEG","volume":"47","author":"X Cui","year":"2016","unstructured":"Cui X, Chopp M, Zacharek A et al (2016) D-4F decreases white matter damage after stroke in mice. Stroke 47:214\u2013220. https:\/\/doi.org\/10.1161\/STROKEAHA.115.011046\/ASSET\/2E82DAF2-7D3C-40AB-A124-4D87A4113832\/ASSETS\/GRAPHIC\/214FIG04.JPEG","journal-title":"Stroke"},{"key":"4859_CR80","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/S40478-017-0429-5\/FIGURES\/8","volume":"5","author":"S Saito","year":"2017","unstructured":"Saito S, Yamamoto Y, Maki T et al (2017) Taxifolin inhibits amyloid-\u03b2 oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Acta Neuropathol Commun 5:26. https:\/\/doi.org\/10.1186\/S40478-017-0429-5\/FIGURES\/8","journal-title":"Acta Neuropathol Commun"},{"key":"4859_CR81","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/J.TOXLET.2012.07.002","volume":"213","author":"H Gu","year":"2012","unstructured":"Gu H, Robison G, Hong L et al (2012) Increased \u03b2-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure. Toxicol Lett 213:211\u2013219. https:\/\/doi.org\/10.1016\/J.TOXLET.2012.07.002","journal-title":"Toxicol Lett"},{"key":"4859_CR82","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1016\/J.JMB.2018.08.018","volume":"430","author":"BR Sahoo","year":"2018","unstructured":"Sahoo BR, Genjo T, Cox SJ et al (2018) Nanodisc-forming scaffold protein promoted retardation of amyloid-beta aggregation. J Mol Biol 430:4230\u20134244. https:\/\/doi.org\/10.1016\/J.JMB.2018.08.018","journal-title":"J Mol Biol"},{"key":"4859_CR83","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.MOLPHARMACEUT.4C00633\/ASSET\/IMAGES\/MEDIUM\/MP4C00633_0007.GIF","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhong R, Curran GL et al (2024) High-density lipoprotein mimetic peptide 4F reduces toxic amyloid-beta exposure to the blood-brain barrier endothelium in Alzheimer\u2019s disease transgenic mice. Mol Pharm. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.4C00633\/ASSET\/IMAGES\/MEDIUM\/MP4C00633_0007.GIF","journal-title":"Mol Pharm"},{"key":"4859_CR84","doi-asserted-by":"publisher","unstructured":"Lu N, Moran-Losada P, Hahn O, et al (2024) Circulatory proteins shape microglia state and boost phagocytosis. bioRxiv 2024.09.30.615861. https:\/\/doi.org\/10.1101\/2024.09.30.615861","DOI":"10.1101\/2024.09.30.615861"},{"key":"4859_CR85","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/IJMS17030338","volume":"17","author":"YS Batarseh","year":"2016","unstructured":"Batarseh YS, Duong QV, Mousa YM et al (2016) Amyloid-\u03b2 and astrocytes interplay in amyloid-\u03b2 related disorders. Int J Mol Sci 17:338. https:\/\/doi.org\/10.3390\/IJMS17030338","journal-title":"Int J Mol Sci"},{"key":"4859_CR86","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/FNMOL.2017.00427\/BIBTEX","volume":"10","author":"RE Gonz\u00e1lez-Reyes","year":"2017","unstructured":"Gonz\u00e1lez-Reyes RE, Nava-Mesa MO, Vargas-S\u00e1nchez K et al (2017) Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci 10:427. https:\/\/doi.org\/10.3389\/FNMOL.2017.00427\/BIBTEX","journal-title":"Front Mol Neurosci"},{"issue":"117","key":"4859_CR87","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/S00702-010-0433-4","volume":"1178","author":"CYD Lee","year":"2010","unstructured":"Lee CYD (2010) Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 1178(117):949\u2013960. https:\/\/doi.org\/10.1007\/S00702-010-0433-4","journal-title":"J Neural Transm"},{"key":"4859_CR88","doi-asserted-by":"publisher","first-page":"110961","DOI":"10.1016\/J.CELREP.2022.110961\/ATTACHMENT\/AE2B78A4-554F-401E-8B38-4D8D2BFBF226\/MMC1.PDF","volume":"39","author":"S Kiani Shabestari","year":"2022","unstructured":"Kiani Shabestari S, Morabito S, Danhash EP et al (2022) Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice. Cell Rep 39:110961. https:\/\/doi.org\/10.1016\/J.CELREP.2022.110961\/ATTACHMENT\/AE2B78A4-554F-401E-8B38-4D8D2BFBF226\/MMC1.PDF","journal-title":"Cell Rep"},{"key":"4859_CR89","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/J.IMMUNI.2022.10.016","volume":"55","author":"X Chen","year":"2022","unstructured":"Chen X, Holtzman DM (2022) Emerging roles of innate and adaptive immunity in Alzheimer\u2019s disease. Immunity 55:2236\u20132254. https:\/\/doi.org\/10.1016\/J.IMMUNI.2022.10.016","journal-title":"Immunity"},{"key":"4859_CR90","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cvr\/cvu150","volume":"103","author":"AL Catapano","year":"2014","unstructured":"Catapano AL, Pirillo A, Bonacina F, Norata GD (2014) HDL in innate and adaptive immunity. Cardiovasc Res 103:372\u2013383","journal-title":"Cardiovasc Res"},{"key":"4859_CR91","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/JIR.S12983","volume":"4","author":"GS Getz","year":"2011","unstructured":"Getz GS, Reardon CA (2011) Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis. J Inflamm Res 4:83. https:\/\/doi.org\/10.2147\/JIR.S12983","journal-title":"J Inflamm Res"},{"key":"4859_CR92","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/STROKEAHA.111.627562","volume":"43","author":"AMS Hartz","year":"2012","unstructured":"Hartz AMS, Bauer B, Soldner ELB et al (2012) Amyloid-\u03b2 contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43:514\u2013523. https:\/\/doi.org\/10.1161\/STROKEAHA.111.627562","journal-title":"Stroke"},{"key":"4859_CR93","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.3233\/JAD-140027","volume":"42","author":"J Ghiso","year":"2014","unstructured":"Ghiso J, Fossati S, Rostagno A (2014) Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells. J Alzheimer\u2019s Dis 42:S167\u2013S176. https:\/\/doi.org\/10.3233\/JAD-140027","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4859_CR94","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/J.ISCI.2021.102993","volume":"24","author":"JA Aguilar-Pineda","year":"2021","unstructured":"Aguilar-Pineda JA, Vera-Lopez KJ, Shrivastava P et al (2021) Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease. iScience 24:102993. https:\/\/doi.org\/10.1016\/J.ISCI.2021.102993","journal-title":"iScience"},{"key":"4859_CR95","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/J.JMB.2019.01.045","volume":"431","author":"A McQuade","year":"2019","unstructured":"McQuade A, Blurton-Jones M (2019) Microglia in Alzheimer\u2019s disease: exploring how genetics and phenotype influence risk. J Mol Biol 431:1805\u20131817. https:\/\/doi.org\/10.1016\/J.JMB.2019.01.045","journal-title":"J Mol Biol"},{"key":"4859_CR96","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/ANNUREV-IMMUNOL-051116-052358\/CITE\/REFWORKS","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/ANNUREV-IMMUNOL-051116-052358\/CITE\/REFWORKS","journal-title":"Annu Rev Immunol"},{"key":"4859_CR97","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/JCB.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217:459. https:\/\/doi.org\/10.1083\/JCB.201709069","journal-title":"J Cell Biol"},{"issue":"3","key":"4859_CR98","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/10738584211040786","volume":"29","author":"W Qu","year":"2023","unstructured":"Qu W, Li L (2023) Microglial TREM2 at the intersection of brain aging and Alzheimer\u2019s disease. Neuroscientist. 29(3):302\u201316. https:\/\/doi.org\/10.1177\/10738584211040786","journal-title":"Neuroscientist."},{"key":"4859_CR99","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/BRAIN\/AWV379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso A, Schetters STT, Sri S et al (2016) Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain 139:891\u2013907. https:\/\/doi.org\/10.1093\/BRAIN\/AWV379","journal-title":"Brain"},{"issue":"80","key":"4859_CR100","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1126\/SCIENCE.1078259\/SUPPL_FILE\/PFEIFERSOM2.PDF","volume":"298","author":"M Pfeifer","year":"2002","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L et al (2002) Cerebral hemorrhage after passive anti-a\u03b2 immunotherapy. Science 298(80):1379. https:\/\/doi.org\/10.1126\/SCIENCE.1078259\/SUPPL_FILE\/PFEIFERSOM2.PDF","journal-title":"Science"},{"key":"4859_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-023-00649-W\/FIGURES\/5","volume":"18","author":"X Taylor","year":"2023","unstructured":"Taylor X, Clark IM, Fitzgerald GJ et al (2023) Amyloid-\u03b2 (A\u03b2) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer\u2019s disease mice. Mol Neurodegener 18:1\u201316. https:\/\/doi.org\/10.1186\/S13024-023-00649-W\/FIGURES\/5","journal-title":"Mol Neurodegener"},{"key":"4859_CR102","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1172\/JCI123700","volume":"129","author":"D Meriwether","year":"2019","unstructured":"Meriwether D, Sulaiman D, Volpe C et al (2019) Apolipoprotein A-I mimetics mitigate intestinal inflammation in a COX2-dependent inflammatory disease model. J Clin Invest 129:3670\u20133685. https:\/\/doi.org\/10.1172\/JCI123700","journal-title":"J Clin Invest"},{"key":"4859_CR103","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1194\/JLR.M067025","volume":"57","author":"D Meriwether","year":"2016","unstructured":"Meriwether D, Sulaiman D, Wagner A et al (2016) Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux. J Lipid Res 57:1175. https:\/\/doi.org\/10.1194\/JLR.M067025","journal-title":"J Lipid Res"},{"key":"4859_CR104","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MOL.0000000000000472","volume":"29","author":"K Nakaya","year":"2018","unstructured":"Nakaya K, Ikewaki K (2018) Microbiota and HDL metabolism. Curr Opin Lipidol 29:18\u201323. https:\/\/doi.org\/10.1097\/MOL.0000000000000472","journal-title":"Curr Opin Lipidol"},{"key":"4859_CR105","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/JCM9051589","volume":"9","author":"KE Yun","year":"2020","unstructured":"Yun KE, Kim J, Kim MH et al (2020) Major lipids, apolipoproteins, and alterations of gut microbiota. J Clin Med 9:1589. https:\/\/doi.org\/10.3390\/JCM9051589","journal-title":"J Clin Med"},{"issue":"18","key":"4859_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-023-00595-7","volume":"181","author":"S Chandra","year":"2023","unstructured":"Chandra S, Sisodia SS (2023) Vassar RJ (2023) The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored. Mol Neurodegener 181(18):1\u201321. https:\/\/doi.org\/10.1186\/S13024-023-00595-7","journal-title":"Mol Neurodegener"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04859-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:14:25Z","timestamp":1757146465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04859-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4859"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04859-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Minnesota.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have reviewed and approved the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}